Gan & Lee Pharmaceuticals. (SHA:603087)

SHA:603087 Revenue

Gan & Lee Pharmaceuticals. had revenue of 930.11M CNY in the quarter ending September 30, 2024, with 37.61% growth. This brings the company's revenue in the last twelve months to 2.95B, up 23.78% year-over-year. In the year 2023, Gan & Lee Pharmaceuticals. had annual revenue of 2.61B with 52.31% growth.

• Revenue (ttm): 2.95B
• Revenue Growth: +23.78%
• P/S Ratio: 8.94
• Revenue / Employee: 657.60K
• Employees: 4,482
• Market Cap: 26.71B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.61B	895.77M	52.31%
Dec 31, 2022	1.71B	-1.90B	-52.60%
Dec 31, 2021	3.61B	250.16M	7.44%
Dec 31, 2020	3.36B	466.82M	16.12%
Dec 31, 2019	2.90B	507.68M	21.26%